Effects of Antimalarials on the Pharmacokinetics of Co-Administered Drugs
作者： Tony K. L. Kiang , Kyle John Wilby , Mary H. H. Ensom
DOI: 10.1007/978-3-319-10527-7_5
关键词: Pharmacokinetics 、 Pharmacology 、 Artemisinin 、 Mefloquine 、 Proguanil 、 Artesunate 、 Amodiaquine 、 Artemether 、 Medicine 、 Atovaquone
摘要: This chapter provides details of studies that describe drug interactions in which antimalarial drugs affect the pharmacokinetics various co-administered (non-antimalarial) drugs. These antimalarials include amodiaquine, artemether, artemisinin, artesunate, atovaquone, chloroquine, mefloquine, proguanil, and quinine.
springer.com
sci-hub.st 参考文章(52)
O. O. Simooya, G. Sijumbil, M. S. Lennard, G. T. Tucker, Halofantrine and chloroquine inhibit CYP2D6 activity in healthy Zambians. British Journal of Clinical Pharmacology. ,vol. 45, pp. 315- 317 ,(1998) , 10.1046/J.1365-2125.1998.00671.X
Carol Braun Trapnell, Raymond W. Klecker, Carlos Jamis-Dow, Jerry M. Collins, Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes : relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid Antimicrobial Agents and Chemotherapy. ,vol. 42, pp. 1592- 1596 ,(1998) , 10.1128/AAC.42.7.1592
Bradley M. Kerr, Kenneth E. Thummel, Colleen J. Wurden, Susan M. Klein, Deanna L. Kroetz, Frank J. Gonzalez, RenéH. Levy, HUMAN LIVER CARBAMAZEPINE METABOLISM. ROLE OF CYP3A4 AND CYP2C8 IN 10, 11-EPOXIDE FORMATION Biochemical Pharmacology. ,vol. 47, pp. 1969- 1979 ,(1994) , 10.1016/0006-2952(94)90071-X
M Mahindi, U Hellgren, M S Ntale, JW Ogwal-Okeng, LL Gustafsson, C Obua, W W Anokbonggo, Lundblad, Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda. African Health Sciences. ,vol. 6, pp. 86- 92 ,(2006) , 10.5555/AFHS.2006.6.2.86
Adedayo Adedoyin, Reginald F. Frye, Kelly Mauro, Robert A. Branch, Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail British Journal of Clinical Pharmacology. ,vol. 46, pp. 215- 219 ,(1998) , 10.1046/J.1365-2125.1998.00765.X
Julia A. Hasler, Ann-Charlotte Egnell, Collen M. Masimirembwa, Tashinga E. Bapiro, Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metabolism and Disposition. ,vol. 29, pp. 30- 35 ,(2001)
Jackie L. Miller, Lauren A. Trepanier, Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation. European Journal of Clinical Pharmacology. ,vol. 58, pp. 69- 72 ,(2002) , 10.1007/S00228-002-0424-Y
Michael Wandell, J Robert Powell, W David Hager, Paul E Fenster, Penelope E Graves, Kenneth A Conrad, Steven Goldman, Effect of quinine on digoxin kinetics Clinical Pharmacology & Therapeutics. ,vol. 28, pp. 425- 430 ,(1980) , 10.1038/CLPT.1980.183
COLLEN M. MASIMIREMBWA, LARS L. GUSTAFSSON, MARJA‐LIISA DAHL, YAKOUB ADEN ABDI, JULIA A. HASLER, Lack of effect of chloroquine on the debrisoquine (CYP2D6) and S‐mephenytoin (CYP2C19) hydroxylation phenotypes British Journal of Clinical Pharmacology. ,vol. 41, pp. 344- 346 ,(2003) , 10.1046/J.1365-2125.1996.30713.X
Tashinga E. Bapiro, Jane Sayi, Julia A. Hasler, Mary Jande, Gerald Rimoy, Amos Masselle, Collen M. Masimirembwa, Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans European Journal of Clinical Pharmacology. ,vol. 61, pp. 755- 761 ,(2005) , 10.1007/S00228-005-0037-3